(Total Views: 103)
Posted On: 01/19/2022 11:34:40 AM
Post# of 36224
$QNTA #BreakingNews ! Medolife Rx, Inc. ("Medolife"
(OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of QNTA product, Escozine, as a COVID-19 treatment. https://finance.yahoo.com/news/medolife-rx-su...00052.html
(OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of QNTA product, Escozine, as a COVID-19 treatment. https://finance.yahoo.com/news/medolife-rx-su...00052.html 
(0)
(0)
